As the risks of cancer increase among Japan's aging population, immunologist Tasuku Honjo is pinning his hopes on cancer treatments that shift the paradigm from traditional approaches directly targeting cancer cells to ones that stimulate the body's immune system to fight the disease.Nobel laureate Honjo, 77, believes his research can help bring about a cure -- or at least turn cancer into a nonfatal chronic disease -- while the jury is still out on whether immunotherapy can become a first-line treatment option."Certain types of cancer patients are finally being cured thanks to immunotherap…READ FULL ARTICLE
